{"id":219,"date":"2015-01-30T17:51:03","date_gmt":"2015-01-30T22:51:03","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=219"},"modified":"2015-01-30T17:57:44","modified_gmt":"2015-01-30T22:57:44","slug":"ipo-week-ahead-schedule-week-of-february-2nd","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-week-ahead-schedule-week-of-february-2nd\/","title":{"rendered":"IPO Week Ahead Schedule: Week of February 2nd"},"content":{"rendered":"<p><strong>Week of Feb. 2nd<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/EyegatePharmaceuticalsInc-EYEG-info.php\" target=\"_blank\">Eyegate Pharmaceuticals (Nasdaq: EYEG)<\/a><\/p>\n<p><strong>Wednesday<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AltheaDx-IDGX\" target=\"_blank\">AltheaDx, Inc (Nasdaq: IDGX)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Infraredx-REDX\" target=\"_blank\">Infraredx (Nasdaq: REDX)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/CarbylanTherapeutics-CBYL\" target=\"_blank\">Carbylan Therapeutics (Nasdaq: CBYL)<\/a><\/p>\n<p><strong>Thursday<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AsanteSolutions-PUMP\" target=\"_blank\">Asante Solutions, Inc. (Nasdaq: PUMP)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InotekPharmaceuticals-ITEK\" target=\"_blank\">Inotek Pharmaceuticals Corporation (Nasdaq: ITEK)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/NexvetBiopharma-NVET\" target=\"_blank\">Nexvet Biopharma plc (Nasdaq: NVET)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AdvancedAcceleratorApplications-AAAP\">Advanced Accelerator Applications S.A. (Nasdaq: AAAP)<\/a><\/p>\n<p><strong>Friday<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Check-CapLtd-CHEK\" target=\"_blank\">Check-Cap Ltd (Nasdaq: CHEK)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/ColumbiaPipelinePartners-CPPL\" target=\"_blank\">Columbia Pipeline Partners LP (NYSE: CPPL)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Easterly%20Government%20Properties-DEA\" target=\"_blank\">Easterly Government Properties (NYSE: DEA)<\/a><\/p>\n<p><em><strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscribe now <\/a><\/strong>to get our full research report, IPO summary and senior managing partner Scott Sweet\u2019s ratings for this week. There are weekly, monthly and annual plans available.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Week of Feb. 2nd Eyegate Pharmaceuticals (Nasdaq: EYEG) Wednesday AltheaDx, Inc (Nasdaq: IDGX) Infraredx (Nasdaq: REDX) Carbylan Therapeutics (Nasdaq: CBYL) Thursday Asante Solutions, Inc. (Nasdaq: PUMP) Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) Nexvet Biopharma plc (Nasdaq: NVET) Advanced Accelerator Applications S.A. (Nasdaq: AAAP) Friday Check-Cap Ltd (Nasdaq: CHEK) Columbia Pipeline Partners LP (NYSE: CPPL) Easterly Government[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[34,81,84,61,63,79,80,83,64,82,32],"class_list":["post-219","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-aaap","tag-cbyl","tag-chek","tag-cppl","tag-dea","tag-eyeg","tag-igdx","tag-itek","tag-nvet","tag-pump","tag-redx"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=219"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/219\/revisions"}],"predecessor-version":[{"id":223,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/219\/revisions\/223"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}